Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

American Journal of Psychiatry

Volumn 153, Issue 9, 1996, Pages 1147-1153

  Wilens, Timothy E ^a   Biederman, Joseph ^a   Prince, Jefferson ^a   Spencer, Thomas J ^a   Faraone, Stephen V ^a   Warburton, Rebecca ^a   Schleifer, David ^a   Harding, Meg ^a   Linehan, Colleen ^a   Geller, Daniel ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL BRAIN DYSFUNCTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 9544230671     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.9.1147     Document Type: Article

References (67)

1. Anderson JC, Williams S, McGee R, Silva PA: DSM-III disorders in preadolescent children. Arch Gen Psychiatry 1987; 44:69-76
2. Bird HR, Canino G, Rubio-Stipec M, Gould MS, Ribera J, Sesman M, Woodbury M, Huerras-Goldman S, Pagan A, Sanchez-Lacay A, Moscoso M: Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Arch Gen Psychiatry 1988; 45:1120-1126
3. Safer DJ, Krager JM: A survey of medication treatment for hyperactive/inattentive students. JAMA 1988; 260:2256-2258
4. Bauermeister JJ, Canino G, Bird H: Epidemiology of disruptive behavior disorders, in Child and Adolescent Psychiatric Clinics of North America, vol 3. Edited by Greenhill L. Philadelphia, WB Saunders, 1994, pp 177-194
5. Gittelman R, Mannuzza S, Shenker R, Bonagura N: Hyperactive boys almost grown up, I: psychiatric status. Arch Gen Psychiatry 1985; 42:937-947
6. Weiss G, Hechtman LT: Hyperactive Children Grown Up. New York, Guilford Press, 1986
7. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA: Hyperactive boys almost grown up, V: replication of psychiatric status. Arch Gen Psychiatry 1991; 48:77-83
8. Weiss G: Attention-Deficit Hyperactivity Disorder. Philadelphia, WB Saunders, 1992
9. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M: Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50:565-576
10. Spencer T, Biederman J, Wilens TE, Faraone SV, Li T: Is attention deficit hyperactivity disorder in adults a valid diagnosis? Harvard Rev Psychiatry 1994; 1:326-335
11. Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N: A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 1990; 31:416-425
12. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150:1792-1798
13. Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148:564-577
14. Shaywitz BA, Shaywitz SE: Comorbidity: a critical issue in attention deficit disorder. J Child Neurol 1991; 6:S13-S22
15. Bird HR, Gould MS, Staghezza BM: Patterns of psychiatric comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry 1993; 32:361-368
16. Jensen PS, Shervette RE III, Xenakis SN, Richters J: Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings. Am J Psychiatry 1993; 150:1203-1209
17. Morrison JR, Stewart MA: A family study of the hyperactive child syndrome. Biol Psychiatry 1971; 3:189-195
18. Cantwell D: Psychiatric illness in the families of hyperactive children. Arch Gen Psychiatry 1972; 27:414-417
19. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B: Further evidence for family-genetic risk factors in attention deficit disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49:728-738
20. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, Sprich S, Tsuang MT: Segregation analysis of attention deficit hyperactivity disorder. Psychiatr Genet 1992; 2:257-275
21. Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R: High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry 1995; 152:431-435
22. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, Hamburger S, Cohen RM: Cerebral glucose metabolism in adults with hyperacriviry of childhood onset. N Engl J Med 1990; 323:1361-1366
23. Wilens TE, Prince JB, Biederman J, Spencer TJ: Pharmacotherapy of adult attention-deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 1995; 15:270-279
24. Greenhill LL, Osman BB: Ritalin: Theory and Patient Management. New York, Mary Ann Liebert, 1991
25. Wilens TE, Biederman J: The stimulants. Psychiatr Clin North Am 1992; 15:191-222
26. Spencer T, Wilens TE, Biederman J, Faraone SV, Ahlon S, Lapey K: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434-443
27. Wood DR, Reimherr FW, Wender PH, Johnson GE: Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 1976; 33:1453-1460
28. Wender PH, Reimherr FW, Wood DR: Attention deficit disorder ("minimal brain dysfunction") in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry 1981; 38: 449-456
29. Mattes JA, Boswell L, Oliver H: Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984; 41:1059-1063
30. Gualtieri GT, Ondrusek MG, Finley C: Attention deficit disorder in adults. Clin Neuropharmacol 1985; 8:343-356
31. Wender PH, Reimherr FW, Wood D, Ward M: A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985; 142: 547-552
32. Klein DF, Gittelman R, Quitkin F, Rifkin A: Diagnosis and drug treatment of childhood disorders, in Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Edited by Klein DF, Gittelman R, Quitkin F, Rifkin A, Baltimore, Williams & Wilkins, 1980, pp 590-775
33. Garfinkel BD, Wender PH, Sloman L, O'Neill I: Tricyclic anti-depressants and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry 1983; 2:343-348
34. Donnelly M, Zametkin AJ, Rapoport JL: Treatment of childhood hyperactivity with desipramine; plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response, Clin Pharmacol Ther 1986; 39:72-81
35. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz, JS: A double-blind placebo controlled study of desipramine in the treatment of ADD, I; efficacy. J Am Acad Child Adolesc Psychiatry 1989; 28:777-784
36. Rapport MD, Carlson GA, Kelly KL, Pataki C: Methylphenidate and desipramine in hospitalized children, I: separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 1993; 32:333-342
37. Magee R, Maier D, Reesal RT: ADHD and desipramine (letter). Can J Psychiatry 1992; 37:149-150
38. Ratey JJ, Greenberg MS, Bemporad JR, Lindem KJ: Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol 1992; 2:267-275
39. Wilens TE, Biederman J, Mick F, Spencer T: A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 1995; 184: 48-50
40. Wilens TE, Biederman J, Baldessarini RJ, Puopolo P, Flood J: Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. J Am Acad Child Adolesc Psychiatry 1992; 31:691-699
41. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R-Non-Patient Edition (SCIDNP, Version 1.0). Washington, DC, American Psychiatric Press, 1990
42. Orvaschel H: Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull 1985; 21: 737-745
43. Ward MF, Wender PH, Reimherr FW: The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150:885-890
44. Wechsler D: Manual for the Wechsler Adult Intelligence Scale - Revised. San Antonio, Tex. Psychological Corp, 1981
45. Jastak S, Wilkinson GS: The Wide Range Achievement Test - Revised. Wilmington, Del, Jastak Associates, 1985
46. Faraone SV, Santangelo S: Methods in Genetic Epidemiology, in Research Designs and Methods in Psychiatry. Edited by Fava M, Rosenbaum JE. Amsterdam, Netherlands, Elsevier, 1992, pp 93-118
47. Hollingshead AB: Four-Factor Index of Social Status. New Haven, Conn, Yale University, Department of Sociology, 1975
48. Conners CK, Barkley RA: Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 1985; 21:809-843
49. Barkley RA: Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, Guilford Press, 1990
50. DuPaul G: The ADHD Rating Scale: Normative Data, Reliability, and Validity. Worcester, University of Massachusetts Medical School, 1990
51. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
52. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
53. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
54. Puopolo PR, Flood JG: Detection of interference by cyclobenzaprine in liquid chromatographic assays of tricyclic antidepressants. Clin Chem 1987; 33:819-820
55. Bailor JC, Mosteller F: Medical Uses of Statistics. Waltham, Mass, New England Journal of Medicine Books, 1986
56. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea T, Imber SD, Sotsky SM, Watkins JT: Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50:739-750
57. Stein MA, Sandoval R, Szumowski E, Roizen N, Reinecke MA, Blondis TA, Klein Z: Psychometric characteristics of the Wender Utah Rating Scale: reliability and factor structure for men and women. Psychopharmacol Bull 1995; 31:423-431
58. Gualtieri CT, Hicks RE: Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity. Psychiatr Clin North Am 1985; 8:875-892
59. Zametkin AJ, Rapoport JL: Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987; 26:676-686
60. Flia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS: Stimulant drug treatment of hyperactivity: biochemical correlates. Clin Pharmacol Ther 1990; 48:57-66
61. Huessy HR: The adult hyperkinetic (letter). Am J Psychiatry 1974; 131:724-725
62. Rapoport JL, Quinn PO, Bradbard G, Riddle KD, Brooks E: Imipramine and methylphenidate treatments of hyperactive boys: a double-blind comparison. Arch Gen Psychiatry 1974; 30:789-793
63. Quinn PO, Rapoport JL: One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 1875; 132:241-245
64. Gastfriend DR, Biederman J, Jellinek MS: Desipramine in the treatment of adolescents with attention deficit disorder. Am J Psychiatry 1984; 141:906-908
65. Biederman J, Gastfriend DR, Jellinek MS: Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986; 6:359-363
66. Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T: Nortriptyline in the treatment of ADHD: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993; 32:343-349
67. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A: A double-blind placebo controlled study of desipramine in the treatment of ADD, II: serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 1989; 28:903-911